| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aef54c233bb892661418586b260708e6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| filingDate |
2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc9e9701cdac74a3d66c4915e715b233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e391b2d2be2430e9f080f67064b0f53c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1be4bbfdd4f83fcf6598c00c1ea668bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe0d86783c114286e3ad0dda4ca513d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3735b682ad3626b599ad8c3f354e4782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a3547f911f38705d4206f192375b433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be74c355b49bcb05b2af8c79ac48b8be |
| publicationDate |
2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2600920-A2 |
| titleOfInvention |
Subconjunctival implant for posterior segment drug delivery |
| abstract |
A therapeutic device can be configured to place the reservoir substantially between the conjunctiva and the sclera such that the size of the reservoir can be increased and the size of the scleral penetration decreased so as to decrease invasiveness. The device may comprise a substantially constant reservoir volume and drug release mechanism, in which the volume of the reservoir and mechanism are tuned to receive a quantity of therapeutic agent with a volume of injected formulation and release the therapeutic agent for an extended time with a release rate profile. The porous structure may comprise a first side coupled to the reservoir and a second side to couple to the patient to release the therapeutic agent, and a plurality of interconnecting channels can extend from the first side to the second side. |
| priorityDate |
2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |